Skip to main content

Table 2 Clinical and outcome information for dogs diagnosed with idiopathic vestibular syndrome

From: Clinical signs, MRI findings and outcome in dogs with peripheral vestibular disease: a retrospective study

 Total number of dogs (n = 128)
AgeMedian 84.5 months (range 15–175)
SexMale n = 78/128 (61%)
Female n = 50/128 (39%)
Onset of clinical signsAcute n = 118/128 (92%)
Chronic n = 10/128 (8%)
Progression of clinical signsProgressive n = 21/122 (17%)
Non-progressive n = 94/122 (77%)
Waxing/waning n = 7/122 (6%)
Neurological abnormalities on examinationHead tilt n = 126/128 (98%)
Nystagmus n = 68/128 (53%)
Ataxia n = 79/128 (61%)
Facial paralysis n = 64/128 (50%)
Positional strabismus n = 61/128 (48%)
Horner syndrome n = 4/128 (3%)
MRI findingsNo abnormalities n = 83/128 (65%)
CN VII enhancement n = 30/128 (23%)
CN VIII enhancement n = 5/128 (4%)
CN VII and VIII enhancement n = 10/128 (8%)
CSF abnormalitiesMild pleocytosis n = 2/81 (2%)
Albuminocytological dissociation = 4/81 (5%)
Outcome informationComplete recovery n = 47/94 (50%)
Persistence of clinical signs n = 47/94 (50%)
Facial paralysis n = 28/94 (30%)
Head tilt n = 25/94 (27%)
Ataxia n = 4/94 (4%)
Recurrence of clinical signsRecurrence n = 19/85 (22%)
No recurrence n = 66/85 (78%)
\